BCMA-CD3 T-cell engager as salvage therapy for multirefractory primary immune thrombocytopenia

The Lancet 2026

View at publisher
Authors: Jesús Duque‐Afonso, Christoph Rummelt, Katharina Förster, Robert Zeiser, Dimitrios Mougiakakos
DOI: 10.1016/s0140-6736(25)02515-2
Cited by: 6
References: 14

Fields of Study & Subjects

Platelet Disorders and Treatments Heparin-Induced Thrombocytopenia and Thrombosis Hemophilia Treatment and Research

Publication details

Journal / source
The Lancet
Publisher
Elsevier BV
Volume
407
Issue
10527
Pages
489–491
Publication date
1 January 2026
Language
EN